Label Changes for:
Zytiga (abiraterone acetate) tablets
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
6 ADVERSE REACTIONS
6.2 Post Marketing Experience...addition of non-infectious pneumonitis
- Zytiga can cause fetal harm when administered to a pregnant woman. Zytiga is not indicated for use in women…